Login / Signup

Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study).

Aurore DougéAurélie RavinetAlexandrine CorrigerAurélie CabrespineMathieu WasiakBruno PereiraHarry SokolStéphanie NguyenJacques-Olivier Bay
Published in: BMJ open (2023)
NCT04935684.
Keyphrases
  • stem cell transplantation
  • high dose
  • low dose
  • randomized controlled trial
  • stem cells
  • clinical trial
  • bone marrow
  • open label
  • mesenchymal stem cells
  • hematopoietic stem cell